node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
BAMBI | LOC102457599 | ENSPSIP00000019913 | ENSPSIP00000003778 | BMP and activin membrane bound inhibitor. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.530 |
BAMBI | SMAD2 | ENSPSIP00000019913 | ENSPSIP00000007362 | BMP and activin membrane bound inhibitor. | Mothers against decapentaplegic homolog. | 0.486 |
BAMBI | SMAD3 | ENSPSIP00000019913 | ENSPSIP00000011835 | BMP and activin membrane bound inhibitor. | Mothers against decapentaplegic homolog. | 0.486 |
BAMBI | SMAD7 | ENSPSIP00000019913 | ENSPSIP00000006817 | BMP and activin membrane bound inhibitor. | Mothers against decapentaplegic homolog. | 0.810 |
BAMBI | TGFBR1 | ENSPSIP00000019913 | ENSPSIP00000020416 | BMP and activin membrane bound inhibitor. | Receptor protein serine/threonine kinase; Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. | 0.760 |
BAMBI | TGFBR2 | ENSPSIP00000019913 | ENSPSIP00000005650 | BMP and activin membrane bound inhibitor. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.626 |
K7EXK2_PELSI | K7FUJ5_PELSI | ENSPSIP00000000512 | ENSPSIP00000011705 | Ubiquitin-like domain-containing protein. | HECT domain-containing protein. | 0.667 |
K7EXK2_PELSI | RPS27A | ENSPSIP00000000512 | ENSPSIP00000014184 | Ubiquitin-like domain-containing protein. | Ubiquitin-like domain-containing protein. | 0.988 |
K7EXK2_PELSI | SMURF2 | ENSPSIP00000000512 | ENSPSIP00000011487 | Ubiquitin-like domain-containing protein. | E3 ubiquitin-protein ligase. | 0.667 |
K7EXK2_PELSI | STUB1 | ENSPSIP00000000512 | ENSPSIP00000015567 | Ubiquitin-like domain-containing protein. | STIP1 homology and U-box containing protein 1. | 0.594 |
K7EXK2_PELSI | TGFBR2 | ENSPSIP00000000512 | ENSPSIP00000005650 | Ubiquitin-like domain-containing protein. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.448 |
K7EXK2_PELSI | UBC | ENSPSIP00000000512 | ENSPSIP00000003340 | Ubiquitin-like domain-containing protein. | Uncharacterized protein. | 0.949 |
K7FUJ5_PELSI | K7EXK2_PELSI | ENSPSIP00000011705 | ENSPSIP00000000512 | HECT domain-containing protein. | Ubiquitin-like domain-containing protein. | 0.667 |
K7FUJ5_PELSI | LOC102457599 | ENSPSIP00000011705 | ENSPSIP00000003778 | HECT domain-containing protein. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.462 |
K7FUJ5_PELSI | RPS27A | ENSPSIP00000011705 | ENSPSIP00000014184 | HECT domain-containing protein. | Ubiquitin-like domain-containing protein. | 0.892 |
K7FUJ5_PELSI | SMAD2 | ENSPSIP00000011705 | ENSPSIP00000007362 | HECT domain-containing protein. | Mothers against decapentaplegic homolog. | 0.770 |
K7FUJ5_PELSI | SMAD3 | ENSPSIP00000011705 | ENSPSIP00000011835 | HECT domain-containing protein. | Mothers against decapentaplegic homolog. | 0.770 |
K7FUJ5_PELSI | SMAD7 | ENSPSIP00000011705 | ENSPSIP00000006817 | HECT domain-containing protein. | Mothers against decapentaplegic homolog. | 0.961 |
K7FUJ5_PELSI | TGFBR1 | ENSPSIP00000011705 | ENSPSIP00000020416 | HECT domain-containing protein. | Receptor protein serine/threonine kinase; Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. | 0.894 |
K7FUJ5_PELSI | TGFBR2 | ENSPSIP00000011705 | ENSPSIP00000005650 | HECT domain-containing protein. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.579 |